Medical Malpractice Insurance News

The U.S. Food and Drug Administration cautions that patients can be injured if wearing face masks with metal features or coating during an MRI exam.

HHS confirms physicians can deliver telehealth services across state lines for covered services to fight the spread of COVID-19.

Physicians interested in offering the COVID-19 vaccine should follow the NYS Department of Health’s instructions for enrollment.

MLMIC and HANYS present “Practicing in a Pandemic – Addressing Liability Issues and Maintaining a Safe Environment of Care,” a webinar on navigating the unprecedented operational and clinical challenges caused by the pandemic.

Although the COVID-19 pandemic has disrupted many aspects of patient care, timely follow-up for patients with potential diagnoses of breast cancer is essential for preventing delayed treatment and care.

The NYS Department of Health directs physicians interested in administering the COVID-19 vaccine in their practice or clinic to enroll in the New York State Immunization Information System.

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

To support policyholders as they navigate the pandemic, MLMIC has assembled a summary of predictive tools and technology to guide management and treatment of COVID-19.

Improved treatment of COVID-19 is reducing mortality rates among those hospitalized for the infection, but experts caution the virus remains dangerous.

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.